Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN

Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN

Epithelial ovarian cancer (EOC) is a lethal gynecological cancer, of which paclitaxel resistance is the major factor limiting treatment outcomes, and identification of paclitaxel resistance-related genes is arduous. We obtained transcriptomic data from seven paclitaxel-resistant ovarian cancer cell...

Full description

Bibliographic Details
Main Authors: Qinsiyu Ma, Zhan’ao Liu, Tengyu Wang, Pengfei Zhao, Mingrui Liu, Yifang Wang, Weitong Zhao, Ying Yuan, Shuo Li
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:International Journal of Molecular Sciences
Subjects:
epithelial ovarian cancer
paclitaxel resistance
lipid metabolism
<i>CPT1A</i>
<i>FASN</i>
<i>SCD</i>
Online Access:https://www.mdpi.com/1422-0067/24/22/16503

Internet

https://www.mdpi.com/1422-0067/24/22/16503

Similar Items